Hiromichi Maeda Selected Research

Capecitabine (Xeloda)

6/2023	The clinical impacts of postoperative complications after colon cancer surgery for the clinical course of adjuvant treatment and survival.
1/2018	Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer.
12/2016	A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiromichi Maeda Research Topics

Disease

52	Stomach Neoplasms (Stomach Cancer) 12/2023 - 07/2009
40	Neoplasms (Cancer) 12/2023 - 09/2007
25	Neoplasm Metastasis (Metastasis) 12/2023 - 08/2006
14	Colorectal Neoplasms (Colorectal Cancer) 07/2023 - 10/2014
11	Lymphatic Metastasis 12/2023 - 12/2016
10	Hypoglycemia (Reactive Hypoglycemia) 06/2023 - 09/2009
7	Adenocarcinoma 12/2023 - 12/2014
7	Colonic Neoplasms (Colon Cancer) 06/2023 - 07/2011
6	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 09/2007
4	Carcinoma (Carcinomatosis) 12/2022 - 09/2008
4	Hyperglycemia 09/2021 - 01/2010
4	Ascites 01/2020 - 07/2011
3	COVID-19 02/2024 - 10/2023
3	Esophageal Neoplasms (Esophageal Cancer) 01/2024 - 10/2023
3	Hemorrhage 10/2023 - 07/2012
3	Wounds and Injuries (Trauma) 07/2023 - 09/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2023 - 09/2008
2	Hydronephrosis 12/2023 - 12/2019
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2023 - 06/2009
2	Breast Neoplasms (Breast Cancer) 08/2023 - 11/2018
2	Rectal Neoplasms (Rectal Cancer) 05/2023 - 01/2021
2	Pain (Aches) 01/2023 - 04/2017
2	Disease Progression 12/2022 - 07/2018
2	Cysts 04/2022 - 05/2018
2	Fatigue 08/2021 - 12/2019
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2021 - 06/2010
2	Situs Inversus 03/2021 - 09/2009
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2021 - 05/2017
2	Anemia 01/2021 - 04/2017
2	Diarrhea 12/2014 - 06/2014
2	Diabetes Mellitus 07/2012 - 03/2010
2	Insulin Resistance 01/2011 - 03/2010
2	Critical Illness (Critically Ill) 01/2010 - 09/2009
2	Infections 09/2009 - 09/2009
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 06/2009 - 08/2006
2	Liver Diseases (Liver Disease) 12/2008 - 01/2008
1	Abdominal Pain (Pain, Abdominal) 12/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2023
1	Hemangioma (Angioma) 10/2023
1	Intussusception 10/2023

Drug/Important Bio-Agent (IBA)

15	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 12/2016
6	NivolumabIBA 12/2023 - 07/2018
5	Fluorouracil (Carac)FDA LinkGeneric 06/2023 - 06/2014
5	RamucirumabIBA 12/2022 - 07/2018
5	Blood Glucose (Blood Sugar)IBA 09/2021 - 01/2009
5	Cetuximab (Erbitux)FDA Link 11/2019 - 03/2015
5	Glucose (Dextrose)FDA LinkGeneric 09/2016 - 09/2009
4	Leucovorin (Folinic Acid)FDA Link 06/2023 - 07/2012
4	Panitumumab (Vectibix)FDA Link 12/2022 - 03/2015
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2022 - 11/2016
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 11/2014
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2016
4	Insulin (Novolin)FDA Link 09/2016 - 09/2009
4	Branched-Chain Amino AcidsIBA 07/2013 - 01/2008
3	Capecitabine (Xeloda)FDA Link 06/2023 - 12/2016
3	AcidsIBA 08/2020 - 03/2014
3	ErbB Receptors (EGF Receptor)IBA 11/2019 - 11/2014
2	human ERBB2 proteinIBA 12/2023 - 12/2022
2	Estrogen ReceptorsIBA 08/2023 - 11/2018
2	Bevacizumab (Avastin)FDA Link 07/2023 - 11/2018
2	ZincIBA 01/2023 - 10/2021
2	Serum AlbuminIBA 01/2023 - 10/2021
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 04/2022 - 09/2007
2	Alkaline PhosphataseIBA 10/2020 - 01/2019
2	Diphosphonates (Bisphosphonates)IBA 10/2020 - 11/2016
2	Hemoglobins (Hemoglobin)IBA 10/2020 - 04/2017
2	Trastuzumab (Herceptin)FDA Link 09/2020 - 07/2016
2	Carcinoembryonic AntigenIBA 04/2019 - 02/2018
2	Alanine Transaminase (SGPT)IBA 01/2019 - 12/2016
2	eribulin FDA Link 11/2018 - 11/2016
2	CarbohydratesIBA 04/2018 - 03/2010
2	Tumor Biomarkers (Tumor Markers)IBA 04/2018 - 09/2009
2	XELOXIBA 12/2016 - 10/2015
2	Gemcitabine FDA Link 11/2016 - 09/2008
2	TegafurIBA 01/2015 - 07/2012
2	UracilIBA 01/2015 - 07/2012

Therapy/Procedure

37	Gastrectomy 12/2023 - 07/2009
29	Drug Therapy (Chemotherapy) 12/2023 - 09/2008
23	Lymph Node Excision (Lymph Node Dissection) 12/2023 - 07/2009
23	Therapeutics 12/2023 - 09/2008
13	Adjuvant Chemotherapy 07/2023 - 09/2008
8	Glycemic Control 06/2023 - 09/2009
6	Artificial Pancreas 11/2023 - 01/2009
6	Radiotherapy 10/2023 - 09/2008
5	Pancreaticoduodenectomy 05/2023 - 08/2006
4	Hepatectomy 02/2024 - 09/2007
4	Esophagectomy 01/2024 - 05/2023
4	Colectomy 05/2021 - 07/2012
3	Splenectomy 10/2023 - 07/2018
3	Oral Administration 01/2015 - 03/2010
3	Insulin Infusion Systems 01/2010 - 09/2009
2	Metastasectomy 12/2023 - 11/2018
2	Stents 12/2023 - 01/2023
2	Treatment Delay 11/2023 - 07/2023
2	Ileostomy 01/2023 - 01/2021
2	Ovariectomy (Oophorectomy) 12/2019 - 07/2011
2	Combination Drug Therapy (Combination Chemotherapy) 08/2018 - 01/2018
2	Pancreatectomy 11/2014 - 06/2009
1	Induction Chemotherapy 11/2023
1	Gastroenterostomy 10/2023